RPTX - Repare Therapeutics GAAP EPS of -$0.28 beats by $0.52 revenue of $30.25M beats by $22.57M
2023-08-09 17:46:16 ET
- Repare Therapeutics press release ( NASDAQ: RPTX ): Q2 GAAP EPS of -$0.28 beats by $0.52 .
- Revenue of $30.25M (+4414.9% Y/Y) beats by $22.57M .
- Cash and cash equivalents and marketable securities as of June 30, 2023 were $280.7 million, which Repare believes will be sufficient to fund its planned operations into 2026.
For further details see:
Repare Therapeutics GAAP EPS of -$0.28 beats by $0.52, revenue of $30.25M beats by $22.57M